Menu

Theranos Leaders Indicted For Fraud

Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

Jun 18, 2018
Ashley Yeager

ISTOCK, JASONDOLYElizabeth Holmes, founder and former CEO of the blood-testing company Theranos, and Ramesh Balwani, former president, have been indicted on charges of alleged fraud, The New York Times reported last Friday (June 15).

A grand jury filed criminal charges against Holmes and Balwani on two counts of conspiracy to commit wire fraud and nine counts of wire fraud in the indictment. The pair is accused of conning investors out of hundreds of millions of dollars, deceiving doctors and patients, and putting patients in personal danger. Holmes and Balwani could each spend up to 20 years in prison and be forced to pay $2.7 million in fines, according to STAT News.

Lawyers for Holmes did not respond to request for comment from The Times, but Balwani’s lawyer said in a statement that his client was “innocent and looks forward to clearing his name at trial.”

Theranos’s technology promised to use only a finger prick of blood to test for a range of conditions, including HIV or diabetics’ A1C levels. Holmes was so convinced that the technology would work that she would dog anyone who questioned it, The Times reports.

“This is someone who is so deeply self-deluded by her optimism and faith in herself,” technology consultant Paul Saffo tells The Times. “And delusion is contagious.”

Theranos announced in a statement that Holmes has stepped down as CEO, but she will remain chair of the board of the company.

 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!